Prab: CSV import

2025-02-16T06:06:10Z

CSV import

← Older revision		Revision as of 06:06, 16 February 2025
Line 1:		Line 1:
	{{~~Short description\|Synthetic cannabinoid}}~~		{{DISPLAYTITLE:AB-CHFUPYCA}}
	~~{{Drugbox~~
	~~\| verifiedfields = changed~~
	~~\| verifiedrevid = 477002123~~
	~~\| IUPAC_name = N-[[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl]-1,1-difluoropentylamine~~
	~~\| image =~~ AB-~~CHFUPYCA_chemical_structure.png~~
	~~\| width = 200~~
	}}

	'''AB-CHFUPYCA''' is a synthetic ~~cannabinoid~~ that ~~has been used in scientific research and~~ is a ~~potent agonist~~ of the [[~~cannabinoid receptor~~]]s. It is ~~structurally~~ related to other synthetic ~~cannabinoids such~~ as [[~~AB-FUBINACA]] and [[AB-PINACA~~]].		== Overview ==
			[[File:AB-CHFUPYCA_chemical_structure.png\|thumb\|right\|Chemical structure of AB-CHFUPYCA]]
			'''AB-CHFUPYCA''' is a synthetic compound that belongs to the class of [[designer drugs]]. It is a derivative of the [[cathinone]] family, which is known for its stimulant effects. AB-CHFUPYCA is chemically related to other synthetic cathinones, often referred to as "[[bath salts]]" in the media.

	==Chemical ~~structure~~==		== Chemical Properties ==
	AB-CHFUPYCA is ~~classified as an indole-based synthetic cannabinoid. Its~~ chemical structure includes a 1-(~~cyclohexylmethyl~~)-1H-~~indole core, which is linked to a~~ 1,1-~~difluoropentyl side chain. The presence of the cyclohexylmethyl group and the difluoropentyl chain are characteristic features that influence its binding affinity and activity at cannabinoid receptors~~.		AB-CHFUPYCA is characterized by its unique chemical structure, which includes a pyrrolidine ring. The presence of this ring is a common feature in many synthetic cathinones, contributing to their psychoactive properties. The compound's full chemical name is 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one.

	==Pharmacology==		== Pharmacology ==
	AB-CHFUPYCA acts as a ~~potent agonist at~~ the [[~~CB1 receptor\|CB<sub>1</sub>~~]] ~~and~~ [[~~CB2 receptor\|CB<sub>2</sub>~~]] ~~receptors, which are part of the~~ [[~~endocannabinoid system~~]]. This ~~system is involved in regulating various physiological processes including mood~~, ~~memory~~, ~~appetite~~, and ~~pain sensation. The activation~~ of ~~these receptors by~~ AB-CHFUPYCA ~~can lead~~ to ~~effects similar to those produced by [[tetrahydrocannabinol]] (THC), the active component of [[cannabis]]~~.		The pharmacological effects of AB-CHFUPYCA are similar to those of other synthetic cathinones. It acts primarily as a [[central nervous system]] stimulant, increasing the levels of [[neurotransmitters]] such as [[dopamine]] and [[norepinephrine]] in the brain. This leads to increased alertness, euphoria, and enhanced energy levels. However, the exact mechanism of action and the long-term effects of AB-CHFUPYCA are not well understood due to limited research.

	==~~Legal status~~==		== Usage and Effects ==
	~~The legal status of~~ AB-CHFUPYCA ~~varies by country~~. ~~In many jurisdictions~~, ~~it is classified~~ as ~~a controlled substance due~~ to its potential for abuse ~~and lack~~ of ~~medical use. It is often included in legislation targeting synthetic cannabinoids and "designer drugs~~."		AB-CHFUPYCA is typically used recreationally for its stimulant effects. Users report feelings of euphoria, increased sociability, and heightened sensory perception. However, the use of AB-CHFUPYCA can also lead to adverse effects such as [[anxiety]], [[paranoia]], and [[tachycardia]]. Due to its potency and the potential for abuse, AB-CHFUPYCA is considered a substance of concern by health authorities.

	==~~Potential risks and side effects~~==		== Legal Status ==
	~~As with other synthetic cannabinoids, the use~~ of AB-CHFUPYCA ~~can pose significant health risks~~. ~~These may include [[tachycardia]], [[hypertension]], [[hallucinations]]~~, and ~~[[psychosis]]~~. ~~The variability in potency~~ and the ~~lack of quality control in illicit preparations further increase the risk~~ of ~~adverse effects~~.		The legal status of AB-CHFUPYCA varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. Regulatory agencies continue to monitor and update the legal status of synthetic cathinones as new compounds are developed and identified.

	~~==Research and applications==~~		== Related Pages ==
	AB-CHFUPYCA is primarily used in scientific research to study the [[endocannabinoid system]] and to develop new therapeutic agents. Its potent activity at cannabinoid receptors makes it a useful tool for understanding receptor function and for screening potential drug candidates.		* [[Synthetic cathinones]]

	==Related ~~pages~~==
	* [[Synthetic ~~cannabinoids]]~~
	* [[Cannabinoid receptor]]
	* [[Endocannabinoid system]]
	* [[Designer drugs]]		* [[Designer drugs]]
			* [[Central nervous system stimulants]]
			* [[Bath salts (drug)]]

	~~==Gallery==~~
	~~<gallery>~~
	~~File:AB-CHFUPYCA_chemical_structure.png\|Chemical structure of AB-CHFUPYCA~~
	~~</gallery>~~

	~~[[Category:Synthetic cannabinoids]]~~
	[[Category:Designer drugs]]		[[Category:Designer drugs]]
			[[Category:Synthetic cathinones]]

Prab: CSV import

2025-02-11T21:20:11Z

CSV import

New page

{{Short description|Synthetic cannabinoid}}
{{Drugbox
| verifiedfields = changed
| verifiedrevid = 477002123
| IUPAC_name = N-[[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl]-1,1-difluoropentylamine
| image = AB-CHFUPYCA_chemical_structure.png
| width = 200
}}

'''AB-CHFUPYCA''' is a synthetic cannabinoid that has been used in scientific research and is a potent agonist of the [[cannabinoid receptor]]s. It is structurally related to other synthetic cannabinoids such as [[AB-FUBINACA]] and [[AB-PINACA]].

==Chemical structure==
AB-CHFUPYCA is classified as an indole-based synthetic cannabinoid. Its chemical structure includes a 1-(cyclohexylmethyl)-1H-indole core, which is linked to a 1,1-difluoropentyl side chain. The presence of the cyclohexylmethyl group and the difluoropentyl chain are characteristic features that influence its binding affinity and activity at cannabinoid receptors.

==Pharmacology==
AB-CHFUPYCA acts as a potent agonist at the [[CB1 receptor|CB<sub>1</sub>]] and [[CB2 receptor|CB<sub>2</sub>]] receptors, which are part of the [[endocannabinoid system]]. This system is involved in regulating various physiological processes including mood, memory, appetite, and pain sensation. The activation of these receptors by AB-CHFUPYCA can lead to effects similar to those produced by [[tetrahydrocannabinol]] (THC), the active component of [[cannabis]].

==Legal status==
The legal status of AB-CHFUPYCA varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. It is often included in legislation targeting synthetic cannabinoids and "designer drugs."

==Potential risks and side effects==
As with other synthetic cannabinoids, the use of AB-CHFUPYCA can pose significant health risks. These may include [[tachycardia]], [[hypertension]], [[hallucinations]], and [[psychosis]]. The variability in potency and the lack of quality control in illicit preparations further increase the risk of adverse effects.

==Research and applications==
AB-CHFUPYCA is primarily used in scientific research to study the [[endocannabinoid system]] and to develop new therapeutic agents. Its potent activity at cannabinoid receptors makes it a useful tool for understanding receptor function and for screening potential drug candidates.

==Related pages==
* [[Synthetic cannabinoids]]
* [[Cannabinoid receptor]]
* [[Endocannabinoid system]]
* [[Designer drugs]]

==Gallery==
<gallery>
File:AB-CHFUPYCA_chemical_structure.png|Chemical structure of AB-CHFUPYCA
</gallery>

[[Category:Synthetic cannabinoids]]
[[Category:Designer drugs]]

AB-CHFUPYCA - Revision history

Prab: CSV import

Prab: CSV import